Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Diagnostic Products Corp.

This article was originally published in The Gray Sheet

Executive Summary

President Sidnew Aroesty resigns "for personal reasons," effective Sept. 30, the company says. Aroesty, a 17-year veteran of DPC, will continue to serve on the board and will act as a consultant to the firm. He will be succeeded by Michael Ziering, who most recently served as the firm's vice president of administration. In addition, Aroesty has resigned as president of Cirrus Diagnostics, DPC's wholly owned subsidiary. Douglas Olsen, VP and executive VP for Cirrus, will take over the position

Latest Headlines
See All
UsernamePublicRestriction

Register

MT002847

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel